PUBLICATIONS /
MEDIA
November 2025
GoDx is excited to announce that we have been accepted into the Rapid Response Partnership Vehicle (RRPV), a BARDA-sponsored consortium managed by Advanced Technology International that connects leading government agencies, industry innovators, and research partners focused on strengthening national preparedness and accelerating the next generation of medical countermeasures.
Joining RRPV is a significant milestone for GoDx. It affirms the strategic relevance of our point of care and point of need diagnostic platforms that identify infectious diseases and antimicrobial resistance at the exact moment action is required. This membership expands our access to federal programs, high impact collaborations, and large scale opportunities aligned with biodefense, public health readiness, and national health security.
As part of RRPV, GoDx will help advance initiatives in pandemic readiness, environmental pathogen surveillance, and rapid diagnostic innovation. Our objective is straightforward. Deliver accurate, accessible testing where it is needed most and help decision makers act faster when every minute counts.
We look forward to partnering with RRPV members who share our vision for a more resilient, data driven, and responsive public health ecosystem.
#GoDx #RRPV #BARDA #MedTech #Diagnostics #PublicHealth #AMR #Innovation #Biodefense #HealthSecurity
October 2025
Great news: we’re certified!
We’ve officially received Qualified New Business Venture (QNBV) Program status in Wisconsin
May 2025
Urgent Care Association EVOLVE, Exhibitor and Corporate Sponsor
January 2025
GoDx is named 1 of 5 Phase 2 companies to receive a state matching grant thanks to SBIR Advance Program funding.
May 2024
Center for Technology Commercialization
https://wisconsinctc.org/client-successes/godx-transforming-the-approach-to-gut-health/
October 2023
September 2023
University of Iowa Partnership
June 2022
July 2021
GoDx Is Mentioned As One of the Top Startup Companies of Wisconsin
July 2021
GoDx Receives Its CLIA Certificate of Waiver That Has Been Assigned in the Federal Database. Exciting things to come!
April 2021
GoDx Is Awarded Phase 1 Grant From National Institute of Allergy and Infectious Diseases for Rapid, Point-Of-Need Diagnostic for Sexually Transmitted Infections
November 16, 2020
October 1, 2020
NCATS (@ncats_nih_gov) Tweeted:
#NCATSfunded awardee @ChangHeeKimDX, CEO of @GoDxInc, shares how the #NCATSsbir program is helping accelerate the development of a rapid, inexpensive test for #COVID19 that also illustrates a #TranslationalScience approach to fighting the pandemic: http://bit.ly/3iK8Fn8
September 2020
GoDx Has Been Selected to Participate in the 2020 NIH Innovation Conference (NIC) And Life Sciences Summit (LSS).
The NIC Will Occur During the Afternoon of Tuesday, October 13, 2020, and Lss Will Occur on Tuesday, November 17, and Wednesday, November 18, 2020.
May 20, 2020
NCATS (@ncats_nih_gov) Tweeted:
@ncats_nih_gov
May 4, 2020
#COVID19 News: With an admin supplement from NCATS, @GoDxInc is quickly pivoting its #NCATSfunded diagnostic to develop a rapid, simple point-of-care test to detect novel #coronavirus.
April 22, 2020
GoDx Is Awarded an NIH Grant as a COVID-19 Emergency Administrative Supplement to Our Active $ 2.7 Million Parent Grant on GI Pathogen Test to Develop a Rapid, Instrument-Free Test for COVID-19 That Can Make Testing Available to Community Hospitals and Hospitals That Do Not Have Rt-Pcr Instruments Which Are Needed for the Current Tests.
April 7, 2020
GoDx Is Selected as a Finalist in the Business Plan Competition of the 2020 Wisconsin Governor’s Business Plan Contest.
February 20, 2020
GoDx Establishes LP-CRADA Collaboration With Naval Medical Research Center (NMRC) To Develop a Rapid, Simple, Point-Of-Need Diagnostic for Sepsis for Use in Austere Environments or Resource-Limited Settings.
January 2020
GoDx Begins Clinical Collaboration With the University of Wisconsin-Madison Medical School.
December 17, 2019
GoDx Is Awarded a Supplementary Grant From NIH to Perform Clinical Studies.
November 22, 2019
GoDx Wins 2nd Place at the American Society of Tropical Medicine and Hygiene Astmh Innovations Pitch Competition in Washington DC.
NCATS (@ncats_nih_gov) Tweeted:
Congratulations #NCATSsbir grantee @ChangHeeKimDX on winning 2nd place at the @ASTMH Innovations Pitch Competition #TropMed19! Learn more about GoDx’s success developing a simple paper test for the diarrheal disease here https://t.co/uLypgEN7Lt https://t.co/O9QLnsTM8j
November 7, 2019
GoDx Is Selected to Present in the Elevator Pitch Olympics at the 2019 Wisconsin Early Stage Symposium.
October 2019
GoDx Attends Microtas Conference in Basel Switzerland.
October 7, 2019
GoDx Presents Exhibit and Poster on Rapid Point of Need DNA Detection at the Defense Techconnect in Washington D.C.
July 12, 2019
GoDx Receives a Commercialization Microgrant From Center for Technology Commercialization Ctc From Wisconsin Economic Development Center WEDC.
July 9, 2019
GoDx Is Selected for the Merlin Mentors Program Madison WI.
July 1, 2019
GoDx Is Awarded Phase 1 Cooperative SBIR Grant From NIAID NIH to Develop a “Rapid and Highly Sensitive Point-Of-Care Simple Paper-Based Neonatal Sepsis Test”
June 18, 2019
Innovation Challenge Speaker @ 2019 Techconnect World Business Innovation Program at the Hynes Convention Center, Boston, Massachusetts.
June 10, 2019
GoDx Wins TechConnect Innovation Award.
June 3-6, 2019
GoDx Is Selected for Trade Show Presentation at the Bio Conference in Philadelphia, PA.
May 19, 2019
GoDx is invited to present at the Shark Tank Pitch Session, Digestive Disease Week Conference in San Diego, CA.
DDW DIGESTIVE DISEASE WEEK 2019 SHARK TANK FINALISTS
April 10-12, 2019
GoDx Is Invited to Present at American Gastroenterology Association Tech Summit Innovation Session in San Francisco, CA.
March 21, 2019
GoDx Presents at NIH/Larta Institute Phase 2 Cap Commercialization Acceleration Program Feed Forward Session in Washington DC.
Feb 1, 2019
GoDx Is Awarded a Diversity Grant to Mentor Underrepresented People in Biotech Entrepreneurship.
August 15, 2018
GoDx Is Selected for the NIH/Larta Institute Phase 2 Cap Commercialization Acceleration Program.
August 1, 2018
GoDx is awarded Phase 2 SBIR grant from NCATS/NIH to develop a rapid point of need diagnostic for pathogens that cause diarrheal diseases
AGA Twitter @ Amergastroassn “Congrats to @Changheekimdx With GoDx Our 2018 #Agatech Shark Tank Winner! In Collaboration With @NIH, GoDx Is Relentlessly Developing a Paper-Based Test to Detect the Specific Bugs That Cause Diarrheal Diseases.”
April 5, 2018
GoDx Is Awarded an I-Corps Grant From the NIH for Customer Discovery Research.
Nov 5, 2017
GoDx Presents at the 19th Annual Health and Human Services SBIR Conference Milwaukee, WI.
September 12, 2017
GoDx Is Awarded a Commercialization Grant From Wisconsin Economic Development Center (WEDC).
April 12, 2017
GoDx Is Awarded Phase 1 SBIR Grant From Ncats/NIH to Develop a Rapid Point of Need Diagnostic For Pathogens That Cause Diarrheal Diseases.